Given the critical role exerted by the HECT E3 ligases in the regulation of diverse and important cellular pathways, including WNT, YAP-Hippo, TGF-β, and PI3K/AKT in CRC (Figure 2), these enzymes represent attractive therapeutic targets. The gene discussed is TGFB1; the disease is colorectal carcinoma.